ArticleBMC medical imaging2026
Ensemble learning strategy-based 18 F-FDG PET/CT metabolic habitats radiomics for predicting EGFR mutation and prognosis in LA-NSCLC: a multi-center study.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundEpidermal growth factor receptor (EGFR) status critically guides tyrosine kinase inhibitor therapy in locally advanced non-small cell lung cancer (LA-NSCLC). This study aimed to develop and validate an 18 F-FDG PET/CT-based stacking ensemble model leveraging metabolic habitat radiomics to noninvasively predict EGFR mutations of LA-NSCLC and stratify prognosis in the patients.
methodsThis multicenter study analyzed 313 LA-NSCLC patients divided into training (n = 142), internal testing (n = 61), and external testing (n = 110) cohorts. Tumors were segmented into four spatially distinct, biologically similar metabolic habitat subregions (PEThigh-CThigh, PETlow-CTlow, PETlow-CThigh and PEThigh-CTlow) via Otsu algorithm. Three-step feature selection identified robust and effective radiomic features from various metabolic habitats. The ensemble learning algorithm was applied to develop habitat radiomics and combined clinical-habitat models for prediction of EGFR mutation. Patients were divided into low-risk and high-risk groups based on the median of combined score. Kaplan-Meier survival analysis compared progression free survival (PFS) and overall survival (OS) between two groups.
resultsThe stacking ensemble model exhibited the highest performance, with AUC values of 0.920, 0.900 and 0.884 in training, internal testing and external testing cohorts, outperforming other models. Multimodal integration with clinical features further enhanced performance (AUCs: 0.935/0.921/0.905). Prognostic stratification revealed significant PFS and OS differences between risk groups (all log-rank P < 0.05). Habitat-level analysis identified PEThigh-CThigh habitat volume fraction and PETlow-CThigh habitat voxel count as EGFR mutation correlates.
conclusionThe stacking ensemble model based on 18 F-FDG PET/CT metabolic habitat radiomics demonstrates potential for predicting EGFR mutations in LA-NSCLC. The combined model with a further improved performance by integrating with the clinical feature, and enabled prognostic stratification for LA-NSCLC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.